These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 21466619)

  • 1. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection.
    Long AN; Dagogo-Jack S
    J Clin Hypertens (Greenwich); 2011 Apr; 13(4):244-51. PubMed ID: 21466619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009.
    Tseng LN; Tseng YH; Jiang YD; Chang CH; Chung CH; Lin BJ; Chuang LM; Tai TY; Sheu WH
    J Formos Med Assoc; 2012 Nov; 111(11):625-36. PubMed ID: 23217598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension.
    An J; Nichol MB
    Med Care; 2013 Oct; 51(10):879-87. PubMed ID: 23929398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016).
    Esteghamati A; Larijani B; Aghajani MH; Ghaemi F; Kermanchi J; Shahrami A; Saadat M; Esfahani EN; Ganji M; Noshad S; Khajeh E; Ghajar A; Heidari B; Afarideh M; Mechanick JI; Ismail-Beigi F
    Sci Rep; 2017 Oct; 7(1):13461. PubMed ID: 29044139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications.
    Babel RA; Dandekar MP
    Curr Diabetes Rev; 2021; 17(4):457-473. PubMed ID: 33143626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
    Levy P
    Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data.
    Gabriel R; Boukichou Abdelkader N; Acosta T; Gilis-Januszewska A; Gómez-Huelgas R; Makrilakis K; Kamenov Z; Paulweber B; Satman I; Djordjevic P; Alkandari A; Mitrakou A; Lalic N; Colagiuri S; Lindström J; Egido J; Natali A; Pastor JC; Teuschl Y; Lind M; Silva L; López-Ridaura R; Tuomilehto J;
    PLoS One; 2020; 15(4):e0231196. PubMed ID: 32282852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between C peptide and chronic complications in type-2 diabetes mellitus.
    Sari R; Balci MK
    J Natl Med Assoc; 2005 Aug; 97(8):1113-8. PubMed ID: 16173326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of obesity hypertension and diabetes syndrome.
    Zanella MT; Kohlmann O; Ribeiro AB
    Hypertension; 2001 Sep; 38(3 Pt 2):705-8. PubMed ID: 11566961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes--including reducing the risk of age and atherosclerosis.
    Hellstrom HR
    Med Hypotheses; 2007; 68(2):415-33. PubMed ID: 16828234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitus.
    Vasudevan AR; Burns A; Fonseca VA
    Treat Endocrinol; 2006; 5(5):273-86. PubMed ID: 17002487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and determinants of comorbid diabetes and hypertension: Evidence from non communicable disease risk factor STEPS survey, India.
    Tripathy JP; Thakur JS; Jeet G; Jain S
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S459-S465. PubMed ID: 28395951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of the complications of diabetes.
    Vinik AI; Vinik E
    Am J Manag Care; 2003 Mar; 9(3 Suppl):S63-80; quiz S81-4. PubMed ID: 12653455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of diabetes, epidemiological characteristics and vascular complications.
    Russo MP; Grande-Ratti MF; Burgos MA; Molaro AA; Bonella MB
    Arch Cardiol Mex; 2023; 93(1):30-36. PubMed ID: 36757785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension with diabetes mellitus complications.
    Yamazaki D; Hitomi H; Nishiyama A
    Hypertens Res; 2018 Mar; 41(3):147-156. PubMed ID: 29353881
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.